Search results for "Acute mi"

showing 8 items of 8 documents

Cost-efficacy of oral triptans in the treatment of acute migraine

2005

SummaryThe objective of this study was to compare the efficiency of oral triptans currently used in the treatment of acute migraine in Spain. Using a decision analytic model, a cost-efficacy analysis was performed from the payer's perspective. Efficacy was assessed in terms of sustained pain-free patients, with data extracted from a recent meta-analysis of clinical trials. Chest-related and central nervous system-related adverse events were also considered. For the economic analysis, the cost of drug treatment and the management of adverse events were determined.A group of three triptans (naratriptan 2.5 mg, sumatriptan 50 mg and almotriptan 12.5 mg) was found to dominate all other triptans…

Acute migraineNaratriptanbusiness.industryHealth PolicyTriptansmedicine.diseaseClinical trialSumatriptanMigraineAlmotriptanAnesthesiamedicinebusinessAdverse effectmedicine.drug
researchProduct

Impact of Fasting Glycemia on Short-Term Prognosis after Acute Myocardial Infarction

2007

The prognosis of patients with acute myocardial infarction (MI), according to the new criteria for impaired fasting glucose (IFG) (FG 100-126 mg/dl), has not been evaluated.A total of 2353 patients with acute MI and surviving at d 5 after admission were analyzed for short-term morbidity and mortality. FG was obtained at d 4 and 5. Patients were classified as diabetes mellitus (known diabetes or FGor = 126 mg/dl), high IFG (110or = FG126 mg/dl), low IFG (100or = FG110 mg/dl), and normal fasting glucose (NFG) (FG100 mg/dl).Among the 2353 patients, 968 (41%) had diabetes mellitus, 262 (11%) had high IFG, 332 (14%) had low IFG, and 791 (34%) had NFG. Compared with NFG patients, 30-d cardiovascu…

Blood GlucoseMalemedicine.medical_specialtyendocrine system diseasesHeart diseaseEndocrinology Diabetes and MetabolismClinical BiochemistryMyocardial InfarctionSensitivity and Specificitybehavioral disciplines and activitiesBiochemistryCohort StudiesFasting glucoseEndocrinologyRisk FactorsInternal medicineDiabetes mellitusDiabetes MellitusPrevalencemedicineHumansMyocardial infarctionAcute miAgedCardiovascular mortalitybusiness.industryBiochemistry (medical)nutritional and metabolic diseasesFastingMiddle AgedPrognosismedicine.diseaseImpaired fasting glucoseEndocrinologyROC CurveHyperglycemiaHeart failureFemaleMorbiditybusinesshormones hormone substitutes and hormone antagonistspsychological phenomena and processesThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for …

2019

Individuals with heterozygous familial hypercholesterolemia (FH) are at high risk of early myocardial infarction (MI). However, coronary artery disease (CAD) burden of FH remains not well described, especially for French patients.The objective of this study was to assess the prevalence of FH and severity of CAD from a large database of a French regional registry of acute MI.All consecutive patients hospitalized for an acute MI in a multicenter database from 2001 to 2017 were considered. FH was diagnosed using an algorithm adapted from the Dutch Lipid Clinic Network criteria. The prevalence and clinical features of FH and the severity of CAD were assessed.Among the 11,624 patients included i…

Heterozygotemedicine.medical_specialtyEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]Myocardial InfarctionFamilial hypercholesterolemia030204 cardiovascular system & hematologySeverity of Illness IndexCohort StudiesHyperlipoproteinemia Type IICoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinePrevalenceInternal MedicinemedicineHumansIn patientRegistries030212 general & internal medicineMyocardial infarctionRisk factorAcute miLipid clinicAgedAged 80 and overNutrition and Dieteticsbusiness.industryCholesterol LDLMiddle AgedEzetimibemedicine.disease3. Good healthLarge cohortHospitalizationFranceHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular Medicinebusiness
researchProduct

Sex-specific differences regarding seasonal variations of incidence and mortality in patients with myocardial infarction in Germany

2019

Seasonal variation regarding the incidence and the short-term mortality of acute myocardial infarction (MI) was frequently reported, but data about sex-specific differences are sparse.We analysed the impact of seasons and temperature on incidence and in-hospital mortality of patients with acute MI in Germany between 2005 and 2015.The nationwide sample comprised 3,008,188 hospitalizations of MI patients (2005-2015). The incidence was 334.7/100,000 citizens/year. Incidence inclined from 316.3 to 341.6/100,000 citizens/year (β 0.17 [0.10 to 0.24], P  0.001), while in-hospital mortality rate decreased from 14.1% to 11.3% (β -0.29 [-0.30 to -0.28], P  0.001). Overall, 377,028 (12.5%) patients di…

MaleMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesSex Factors0302 clinical medicineGermanymedicineHumansIn patientHospital Mortality030212 general & internal medicineMyocardial infarctionSex DistributionAcute miAgedRetrospective Studiesbusiness.industryIncidenceMortality rateIncidence (epidemiology)Seasonalitymedicine.diseaseSex specificHospitalizationSurvival RateSummer seasonFemaleSeasonsCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesForecastingDemographyInternational Journal of Cardiology
researchProduct

Rizatriptan in the treatment of migraine.

2006

Migraine is a common, disabling disorder associated with considerable personal and societal burden. Current guidelines recommend triptans for the acute treatment of migraine unlikely to respond to less effective therapies. Rizatriptan is a second-generation triptan available in tablet or orally disintegrating tablet (wafer) formulations that offers several advantages over other members of its class. Rizatriptan is rapidly absorbed from the gastrointestinal tract and achieves maximum plasma concentrations more quickly than other triptans, providing rapid pain relief. Clinical trials have shown that rizatriptan is at least as effective or superior to other oral migraine-specific agents in the…

Orally disintegrating tabletmedicine.medical_specialtybusiness.industryrizatriptanPain reliefTriptansmedicine.diseaseExpert OpinionRizatriptantriptansacute migraineClinical trialPsychiatry and Mental healthserotonin receptor agonistsMigraineTolerabilityAnesthesiaInternal medicinePlasma concentrationmedicinebusinessBiological Psychiatrymedicine.drugNeuropsychiatric disease and treatment
researchProduct

0133 : Identifying familial hypercholesterolemia from registries of patients with acute myocardial infarction: an algorithm-based approach

2016

Background and aim Familial hypercholesterolemia (FH) is at very high risk of early myocardial infarction (MI). The prevalence of FH, which is estimated to be at least 1:500 in the general population, remains unclear in patients with acute MI. From databases of 3 French regional and nationwide registries of acute MI (RICO and FAST-MI 2005 and 2010, respectively), we aimed to determine FH prevalence by developing a specific algorithm. Methods and results Consecutive patients with AMI ≤48 hours of onset included 1) in FAST-MI : during a one-month period in 223 institutions at the end of 2005 and 213 institutions at the end of 2010, and 2) in RICO :from January 2001 – December 2013 (≈ 13 y), w…

Pediatricsmedicine.medical_specialtyPopulationFamilial hypercholesterolemiaFamilial hypercholesterolemiaDisease030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine030212 general & internal medicineMyocardial infarctionFamily historyeducationAcute miComputingMilieux_MISCELLANEOUSeducation.field_of_studybusiness.industryVascular disease[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.diseaseMyocardial infarctionbusinessCardiology and Cardiovascular MedicineVery high riskAlgorithmArchives of Cardiovascular Diseases Supplements
researchProduct

0133: The Log Book as a new tool for the secondary prevention of coronary artery disease

2016

International audience; IntroductionThe Log book (LB) project was created by a multidisciplinary team of healthcare professionals from a regional care network and aimed to improve secondary prevention (SP) after acute myocardial infarction (MI) in Cote d’Or. LB includes information and advices for increasing self management of risk factors by the patient.MethodsA prospective interventional study on 469 patients hospitalised for an acute MI in the 2 Intensive Coronary Care unit of Côte d’Or (CHU Dijon and Clinique de Fontaine les Dijon) in 2012 and surviving at 1 year follow-up (FU). LB was randomly given at the time of their hospitalisation by the nursing team, also providing oral advices o…

medicine.medical_specialtyPediatrics030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMedicine030212 general & internal medicineMyocardial infarctionRisk factorAcute miSecondary preventionSelf-managementbusiness.industryPrevention[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.disease3. Good healthMyocardial infarctionEmergency medicineCoronary care unitSelf careCardiology and Cardiovascular MedicinebusinessLog book
researchProduct

Magnetic resonance microscopy and correlative histopathology of the infarcted heart

2019

Altres ajuts:The present study was supported by the EU Joint Programming Initiative 'A Healthy Diet for a Healthy Life' (JPI HDHL INTIMIC-085), Generalitat Valenciana (GV/2018/116), INCLIVA and Universitat de Valencia (program VLC-BIOCLINIC 20-nanomIRM-2016A). Delayed enhancement cardiovascular magnetic resonance (MR) is the gold-standard for non-invasive assessment after myocardial infarction (MI). MR microscopy (MRM) provides a level of detail comparable to the macro objective of light microscopy. We used MRM and correlative histopathology to identify infarct and remote tissue in contrast agent-free multi-sequence MRM in swine MI hearts. One control group (n = 3 swine) and two experimenta…

medicine.medical_specialtySwineMyocardial InfarctionIschemiaCardiologylcsh:MedicineDelayed enhancement030204 cardiovascular system & hematologyArticle030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicineAnimalsHumansMyocardial infarctionlcsh:ScienceAcute miMicroscopyMultidisciplinaryintegumentary systemmedicine.diagnostic_testbusiness.industryMagnetic resonance microscopylcsh:RMagnetic resonance imagingDiagnostic markersmedicine.diseaseMagnetic Resonance ImagingDisease Models AnimalInfarcted heartlcsh:QHistopathologyNuclear medicinebusiness
researchProduct